Evaluation of CC mice as an improved model for influenza immunity
Evaluation of CC mice as an improved model for influenza immunity
批准号:
10117187
负责人:
VLADIMIR P BADOVINAC
金额:
$19.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-03-02 至 2023-02-28
关键词:
AddressAffectAllelesAnimal ModelAntibodiesBiologyBreedingCD8-Positive T-LymphocytesCellsChromosome MappingClinicalCollaborationsCommon EpitopeComparative StudyDataDevelopmentDiseaseEnvironmentEpitopesEvaluationExhibitsExperimental ModelsExposure toGeneticGenetic EnhancementGenetic HeterogeneityGenetic VariationGoalsHistocompatibility Antigens Class IHumanImmuneImmune responseImmune systemImmunityImmunologicsImmunologyInbred BALB C MiceInbred MouseInbred StrainInbred Strains MiceInbreedingIndividualInfectionInfluenzaInfluenza A virusInfluenza vaccinationKineticsKnowledgeLaboratoriesLungMemoryModelingMolecularMolecular AnalysisMusOutcomePaperPhenotypePopulationProductivityPublic HealthPublicationsPublishingQuantitative Trait LociRecording of previous eventsReproducibilityResearch PersonnelSingle Nucleotide PolymorphismStructure of parenchyma of lungStudy modelsSymptomsT cell differentiationT cell responseT-LymphocyteTissuesTranscendTranslationsVaccinationViralViral ProteinsVirusVirus DiseasesWorkcohortgenetic manipulationgerm free conditionimprovedin vivoinfluenza infectioninfluenza virus vaccineinsightinterestmouse modelneutralizing antibodypathogenresponseseasonal influenzatooluniversal influenza vaccine
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Influenza infection is a recurring public health burden and our current strategies of seasonal influenza
vaccination provide suboptimal protection. Thus, it is critical to provide basic, mechanistic insights into the
possibility of universal influenza vaccines, as carried out in animal models, and much work is devoted to
strategies to induce broadly neutralizing antibodies. However, in the absence of neutralizing antibodies, the
presence of IAV-specific memory CD8 T cells targeting conserved viral proteins such as NP or M2,
correlate with control of viral titers and reduction of disease symptoms in humans and mice. Mouse models
suggest it is the lung resident memory CD8 T cells (Trm) that enable robust protection against IAV infection.
Most animal models of influenza immunology rely on the sophisticated tools available for studies of
inbred mice. However, our own data suggest that genetic diversity, as manifested in humans and outbred
mice, can markedly affect T cell responses to influenza. Thus, incorporating genetic diversity into mouse
models of influenza immunity may provide improved translational insights along with mechanistic
information. However, each outbred mouse is unique, diminishing their utility. To address this, we propose
to evaluate the genetically diverse Collaborative Cross (CC) mice as a potentially improved model of
influenza immunity. The CC mice exhibit near outbred, but fully characterized genetic diversity, however,
due to the creative breeding approach, each CC line is actually inbred and can be used for repeated
studies, outcrossing to other CC lines to further enhance genetic diversity and genetic mapping studies. Our
long-term goal is to determine if the CC mouse model provides improved insights into the biology of IAV-
induced Trm and how these cells can be manipulated to enhance immunity to aid in development of
universal influenza vaccines. We will address this long-term goal with the following specific aim:
Specific Aim - Determine if genetic diversity in the CC mice will modulate IAV-specific circulating and lung
resident memory CD8 T cell responses and thus, result in an improved animal model of IAV immunity that
reflects the genetic diversity in outbred humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular and molecular mechanisms controlling sepsis-induced immunoparalyses state
-
批准号:10557190
-
项目类别:
-
资助金额:$38.52万
-
财政年份:2020
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Differentiation of pathogen-specific memory CD8 T cell responses
-
批准号:9814211
-
项目类别:
-
资助金额:$23.13万
-
财政年份:2019
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Molecular mechanisms controlling differentiation of memory CD8 T cells
-
批准号:8949463
-
项目类别:
-
资助金额:$22.53万
-
财政年份:2015
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Impairment and recovery of CD8 T cell responses after sepsis
-
批准号:9128672
-
项目类别:
-
资助金额:$30.06万
-
财政年份:2015
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Impairment and recovery of CD8 T cell responses after sepsis
-
批准号:9302800
-
项目类别:
-
资助金额:$29.84万
-
财政年份:2015
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:9884079
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:10534144
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:10317045
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:10077814
-
项目类别:
-
资助金额:$46.03万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T cell localization and protection from influenza
-
批准号:8960855
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2014
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Cellular intermediates in stable memory CD8 T cell maintenance
-
批准号:8250161
-
项目类别:
-
资助金额:$18.82万
-
财政年份:2012
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Cellular intermediates in stable memory CD8 T cell maintenance
-
批准号:8416310
-
项目类别:
-
资助金额:$22.6万
-
财政年份:2012
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T Cell Responses After Multiple Antigen Encounters
-
批准号:7695307
-
项目类别:
-
资助金额:$37.2万
-
财政年份:2009
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T Cell Responses After Multiple Antigen Encounters
-
批准号:8094471
-
项目类别:
-
资助金额:$36.44万
-
财政年份:2009
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T Cell Responses After Multiple Antigen Encounters
-
批准号:7877845
-
项目类别:
-
资助金额:$36.82万
-
财政年份:2009
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
Memory CD8 T Cell Responses After Multiple Antigen Encounters
-
批准号:8286365
-
项目类别:
-
资助金额:$36.43万
-
财政年份:2009
-
负责人:VLADIMIR P BADOVINAC
-
依托单位:
海外基金